{"id":8227,"date":"2020-02-13T17:52:46","date_gmt":"2020-02-13T12:22:46","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=8227"},"modified":"2024-09-18T13:14:20","modified_gmt":"2024-09-18T07:44:20","slug":"recent-pharma-happenings-for-jj-astrazeneca-adc-alx","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx","title":{"rendered":"J&#038;J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\" id=\"h-j-j-collaborates-with-barda-to-accelerate-coronavirus-vaccine-program\"><strong>J&amp;J collaborates with BARDA to accelerate coronavirus vaccine program<\/strong><\/h3>\n\n\n\n<p>Johnson &amp; Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to produce a vaccine against novel <a href=\"https:\/\/www.delveinsight.com\/blog\/coronavirus\">coronavirus<\/a>. J&amp;J is attempting to pool money and resources with BARDA in order to quick the progress of the drug into phase 1 development.\u00a0\u00a0<\/p>\n\n\n\n<p>J&amp;J had joined the biopharma companies that are working to halt the coronavirus, now radiating out from Wuhan, China. The giant had sketched out a multipronged approach against the virus that positioned it to proffer antivirals for use in China while giving its AdVac and PER.C6 technologies to the development of a vaccine.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Presently, J&amp;J has extended its alliance with BARDA, part of the U.S. Department of Health and Human Services, to lift the vaccine development program. The Janssen unit of and BARDA will co-fund R&amp;D on the vaccine, and both make their capital and resources available for the project.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-virus-that-causes-foot-and-mouth-disease-in-cows-helps-in-attacking-pancreatic-cancer\"><strong>The virus that causes foot-and-mouth disease in cows helps in attacking pancreatic cancer.&nbsp;<\/strong><\/h3>\n\n\n\n<p>The scientists at the Queen Mary University of London, AstraZeneca and ADC Therapeutics had identified an ally while questing to tackle the deadly tumour- pancreatic cancer that is still difficult to treat.<\/p>\n\n\n\n<p>The unexpected ally is the virus, which causes foot-and-mouth disease in cows. The researchers discovered that a peptide taken from the foot-and-mouth virus could search for pancreatic cancer cells. According to a new study reported in the journal Theranostics, the peptide guide is armed with a toxic warhead that killed <a href=\"https:\/\/www.delveinsight.com\/report-store\/pancreatic-endocrine-tumor-market\">pancreatic tumors<\/a> in mice and significantly prolonged the animals\u2019 lifespans.<\/p>\n\n\n\n<p>The peptide was taken from the VP1 coat protein of the foot-and-mouth virus. It can aim integrin \u03b1v\u03b26, a protein that is overexpressed in most <a href=\"https:\/\/www.delveinsight.com\/report-store\/advanced-pancreatic-cancer-market\">pancreatic cancers<\/a> but is low or absent in the normal pancreas.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-alx-increases-usd-105-million-for-cd47-cancer-drug\"><strong>ALX increases USD 105 Million for CD47 cancer drug<\/strong><\/h3>\n\n\n\n<p>ALX Oncology has increased USD 105 million<strong>&nbsp;<\/strong>for CD47 cancer drug during mid-phase trials. The Series C round will bolster phase 2 trials of CD47 myeloid checkpoint inhibitor ALX148 with other anti-cancer therapies.<\/p>\n\n\n\n<p>The multiple drug developers had pursued after CD47 when got confirmed of its role in the associations between cancer cells and the immune system. The evidence proposed tumors to avoid immune attacks by upregulating CD47 that lead researchers to block the signal that will expose cancer cells.&nbsp;&nbsp;<br>Though, attempts have made to realize the therapeutic potential of anti-CD47 antibodies that had been dented by haematological adverse events emerging from the fact that the target is present on host cells like red blood cells.&nbsp;&nbsp;<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>J&amp;J collaborates with BARDA to accelerate coronavirus vaccine program Johnson &amp; Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to produce a vaccine against novel coronavirus. J&amp;J is attempting to pool money and resources with BARDA in order to quick the progress of the drug into phase 1 development.\u00a0\u00a0 J&amp;J [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8232,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[61,18043,96,18044,7859,2734,349,18041,639,18042,5789],"industry":[17225],"therapeutic_areas":[17228,17243],"class_list":["post-8227","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-adc-therapeutics","tag-alx-oncology","tag-astrazeneca","tag-cd47-cancer","tag-coronavirus","tag-johnson-and-johnson","tag-latest-pharma-news","tag-pancreatic-tumors","tag-pharma-news","tag-queen-mary-university-of-london","tag-recent-pharma-news","industry-pharmaceutical","therapeutic_areas-oncology","therapeutic_areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>J&amp;J &amp; BARDA collab; Virus attack on cancer cell; ALX invests in CD47 drug<\/title>\n<meta name=\"description\" content=\"Johnson &amp; Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority to produce a vaccine against novel coronavirus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"J&amp;J &amp; BARDA collab; Virus attack on cancer cell; ALX invests in CD47 drug\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority to produce a vaccine against novel coronavirus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-13T12:22:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-18T07:44:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"J&J & BARDA collab; Virus attack on cancer cell; ALX invests in CD47 drug","description":"Johnson & Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority to produce a vaccine against novel coronavirus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx","og_locale":"en_US","og_type":"article","og_title":"J&J & BARDA collab; Virus attack on cancer cell; ALX invests in CD47 drug","og_description":"Johnson & Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority to produce a vaccine against novel coronavirus.","og_url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-02-13T12:22:46+00:00","article_modified_time":"2024-09-18T07:44:20+00:00","og_image":[{"width":768,"height":480,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx","url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx","name":"J&J & BARDA collab; Virus attack on cancer cell; ALX invests in CD47 drug","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj.jpg","datePublished":"2020-02-13T12:22:46+00:00","dateModified":"2024-09-18T07:44:20+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Johnson & Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority to produce a vaccine against novel coronavirus.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-jj-astrazeneca-adc-alx#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj.jpg","width":768,"height":480,"caption":"PHARMA NEWS"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/13175151\/Anuj-300x188.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">ADC Therapeutics<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">ALX Oncology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">AstraZeneca<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">CD47 Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Coronavirus<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Johnson and Johnson<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Latest pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Pancreatic Tumors<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Queen Mary University Of London<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">recent pharma news<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">ADC Therapeutics<\/span>","<span class=\"advgb-post-tax-term\">ALX Oncology<\/span>","<span class=\"advgb-post-tax-term\">AstraZeneca<\/span>","<span class=\"advgb-post-tax-term\">CD47 Cancer<\/span>","<span class=\"advgb-post-tax-term\">Coronavirus<\/span>","<span class=\"advgb-post-tax-term\">Johnson and Johnson<\/span>","<span class=\"advgb-post-tax-term\">Latest pharma news<\/span>","<span class=\"advgb-post-tax-term\">Pancreatic Tumors<\/span>","<span class=\"advgb-post-tax-term\">pharma news<\/span>","<span class=\"advgb-post-tax-term\">Queen Mary University Of London<\/span>","<span class=\"advgb-post-tax-term\">recent pharma news<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on Feb 13, 2020","modified":"Updated on Sep 18, 2024"},"absolute_dates_time":{"created":"Posted on Feb 13, 2020 5:52 pm","modified":"Updated on Sep 18, 2024 1:14 pm"},"featured_img_caption":"PHARMA NEWS","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/8227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=8227"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/8227\/revisions"}],"predecessor-version":[{"id":29587,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/8227\/revisions\/29587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/8232"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=8227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=8227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=8227"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=8227"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=8227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}